scholarly journals What is the role of onabotulinumtoxinA for the management of the overactive bladder symptom complex in 2016?

2016 ◽  
Vol 25 (2) ◽  
pp. 72-74
Author(s):  
Christopher Chapple
2013 ◽  
Vol 5 (5-S2) ◽  
pp. 152
Author(s):  
Sender Herschorn

In addition to the series of lectures summarized in the articleson the preceding pages, the 2011 Canadian UrologyForum also included a series of workshops intended tohelp answer the question: “Does overactive bladder (OAB)exist as a separate entity or is it a symptom complex thatmay be associated with other conditions?”In an effort to arrive at an answer to this question, theparticipants were divided into groups and asked to examinea particular subset of patients with OAB. The subsets were:females, males, neurogenic and elderly. In each of theseworkshops, the participants were asked to answer the followingquestions:• What is the most likely underlying cause?• Are there unique phenotypes that can be identifiedclinically that are linked to a common underlyingpathophysiology?• What is the likelihood of associated disorders of theoutlet or pelvic floor?• What are the most effective treatments?Each of the groups then reported their answers back tothe entire group of participants, after which time they wereasked to vote on the key question. This review provides asummary of the discussions that took place in each groupand concludes with the results of the vote.


2005 ◽  
Vol 95 (3) ◽  
pp. 335-340 ◽  
Author(s):  
Christopher R. Chapple ◽  
Walter Artibani ◽  
Linda D. Cardozo ◽  
David Castro-Diaz ◽  
Michael Craggs ◽  
...  

Prescriber ◽  
2019 ◽  
Vol 30 (1) ◽  
pp. 19-25
Author(s):  
Joon Jae Park ◽  
Christopher Chapple

2020 ◽  
Vol 6 (3) ◽  
pp. 522-530 ◽  
Author(s):  
Christopher R. Chapple ◽  
Emma Mironska ◽  
Adrian Wagg ◽  
Ian Milsom ◽  
David Castro Diaz ◽  
...  

2019 ◽  
Vol 3 (2) ◽  
pp. 55-62
Author(s):  
Bobby Indra Utama ◽  
Widayat Widayat ◽  
Berriandi Arwan

Objective : This study looked at the incidence of overactive bladder (OAB) in KIA poly patients at Pauh Health Center in Padang City using Overactive Bladder Symptomps Score (OABSS).Method : This research is descriptive. The sampling technique was purposive sampling by considering inclusion and exclusion criteria. The inclusion criteria were women of ideal reproductive age (20-35 years) who had given birth spontaneously, were not pregnant, did not suffer from neurological disorders, diabetes, post bladder surgery and or urinary tract infections and were not treated with Overactive Bladder (OAB), while the exclusion criteria are not willing to take part in the study. The study was carried out at the KIA Poly of Pauh City Health Center in Padang during January 2019. The variable in this study was Overactive Bladder (OAB).Result : In this study, 97.22% of respondents experienced complaints of overactive bladder (OAB), (97.14%) experienced an urgent complaint, and only a small percentage (2.86%) of respondents experienced urinary incontinence. The results of this study indicate that respondents who did not experience complaints of overactive bladder (OAB) were respondents with the smallest parity (parity 1).Conclusion : Most respondents experienced complaints of overactive bladder (OAB) and urgency, and only a small proportion of respondents experienced urinary incontinence. The results of this study indicate that respondents who did not experience complaints of overactive bladder (OAB) were respondents with the smallest parity (parity 1).Keywords : overactive bladder (OAB), Urgensi,inkontinensia urin, Overactive Bladder Symptom Scores (OABSS).


2017 ◽  
Vol 25 (4) ◽  
pp. 245-54
Author(s):  
Elita Wibisono ◽  
Harrina E. Rahardjo

Overactive bladder (OAB) is a common condition that is experienced by around 455 million people (11% of the world population) and associated with significant impact in patients’ quality of life. The first line treatments of OAB are conservative treatment and anti-muscarinic medication. For the refractory OAB patients, the treatment options available are surgical therapy, electrical stimulation, and botulinum toxin injection. Among them, percutaneous tibial nerve stimulation (PTNS) is a minimally invasive option that aims to stimulate sacral nerve plexus, a group of nerve that is responsible for regulation of bladder function. After its approval by food and drug administration (FDA) in 2007, PTNS revealed considerable promise in OAB management. In this review, several non-comparative and comparative studies comparing PTNS with sham procedure, anti-muscarinic therapy, and multimodal therapy combining PTNS and anti-muscarinic had supportive data to this consideration.


Sign in / Sign up

Export Citation Format

Share Document